Data

Click on Protocol Number of interest to view study-related documentation or download data files. (DTMC data files are under development.)
Division Study Number Title Investigator(s) Release Date Sort descending
DTMC NIDA-CPU-0008 Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil Reese Jones, M.D. Dec 21, 2017
DTMC NIDA-MDS-0003 Phase I, Double-Blind, Placebo-Controlled Assessment Of Potential Interactions Between Intravenous Cocaine And Ethanol And Oral Disulfiram John D. Roache, Ph.D. Dec 21, 2017
CTN NIDA-CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment John Rotrosen, M.D. Jan 12, 2018
DTMC NIDA-CSP-1019 Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System For The Treatment Of Cocaine Dependence Ahmed Elkashef, M.D., Paul J. Fudala, Ph.D. May 07, 2018
DTMC NIDA-CSP-1021 Double-Blind, Placebo-Controlled Multi-Center Trial Of Baclofen For The Treatment Of Cocaine Dependence Liza Gorgon, M.A. May 07, 2018
DTMC NIDA-CSP-1022 Phase 2, Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System (STS) As An Aid For Smoking Cessation Elbert D. Glover, PhD, FASHA, FAAHB, FRIPH May 07, 2018
DTMC NIDA-CTO-0008 Phase 2, Double-Blind Placebo-Controlled Trial Of Bupropion for the Treatment of Methamphetamine Dependence Richard Rawson, Ph.D. May 07, 2018
DTMC NIDA-CTO-0010 Assessment of Potential Interactions Between Methamphetamine and Bupropion Thomas F. Newton, M.D. May 07, 2018
DTMC NIDA-MDS-0002 Assessment of Interactions Between Methamphetamine and Aripiprazole Thomas F. Newton, M.D. May 07, 2018
CTN NIDA-CTN-0053 Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT) Kevin M. Gray, MD Jul 13, 2018